EXACT SCIENCES CORP - Common Stock (EXAS)

CUSIP: 30063P105

Q1 2019 13F Holders as of 31 Mar 2019

Security identity
Shares outstanding
193,646,400
Holder snapshot
Share change
+157,074
Put/Call ratio
248%
Reported price per share
$86.62
Number of holders
415
Value change
+$48,610,572
Number of buys
220
Number of sells
170

Security key

30063P105

Report period

Q1 2019

Institutions

415

Top holders

10

Ownership snapshot

Top reported holders of EXAS - EXACT SCIENCES CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
415
Shares
112,616,027
Rows available
415
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders
356
Q1 2019 holders
415
Holder diff
59
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 value Q1 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .